Results 251 to 260 of about 113,669 (290)

Editorial: Women in psychiatry 2024: Psychopharmacology. [PDF]

Front Psychiatry
Camarini R, Stadlin A, Jan RK.
europepmc   +1 more source

Impact of antipsychotics, antiparkinsonian drugs, and anthraquinone stimulant laxatives on severe constipation in patients with schizophrenia. [PDF]

PCN Rep
Nadaya T, Inaguma T, Nagao T, Ishida T.
europepmc   +1 more source

Improving Kv7 targeting anticonvulsants ‐ will repurposing save the day?

British Journal of Pharmacology, EarlyView.
Nikita Gamper
wiley   +1 more source

The Effect of Semaglutide With Lifestyle Intervention on the Physical Health of Patients Treated With Antipsychotic Drugs in a Secure Mental Health Setting: Protocol for an Uncontrolled Pretest-Posttest Pilot Mixed Methods Study.

JMIR Res Protoc
Brenisin K, Kinnafick F, King J, Millard L, Arya D, Hodgson E, Huggins M, Simmons-Roberts A, O'Dowd M, Rayment N, Shah P, Breen KC.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antipsychotics

Clinics in Geriatric Medicine, 1990
The multiple medical problems in the geriatric population complicate the issues of diagnosis and management of behavioral symptoms. Systematic evaluation of the etiology, course, and prognosis of behavioral and psychotic symptoms associated with dementia may clarify the indications for treatment.
M, Phillipson, J T, Moranville, D V, Jeste, M J, Harris   +3 more
openaire   +2 more sources

Antipsychotics in pregnancy

Journal of Psychiatric and Mental Health Nursing, 2010
Women who are pregnant and who have a history of psychosis are commonly managed with antipsychotic medications. The evidence regarding the use of antipsychotics in pregnancy has been insufficient to provide adequate support for this practice and is a concern for clinicians and women alike.
K, McCauley-Elsom, C, Gurvich, S J, Elsom, J, Kulkarni   +3 more
openaire   +2 more sources

Antipsychotic Polypharmacy

Current Pharmaceutical Design, 2004
The administration of more than one drug for a single medical condition is considered to be polypharmacy. There are many possible reasons for polypharmacy: (1) psychosis is a chronic disease that cannot be cured; (2) expectations to improve patients' quality of life beyond what drugs can actually do is high; (3) the lack of side effects and ...
J, Ananth, S, Parameswaran, S, Gunatilake   +2 more
openaire   +2 more sources

Antipsychotics as antidepressants

Asia-Pacific Psychiatry, 2015
AbstractThree second‐generation antipsychotic (SGA) agents have receivedFDAapproval for adjunctive treatment, to antidepressant, of major depressive disorder: quetiapine, aripiprazole, and olanzapine. Additionally, quetiapine and lurasidone have been approved for the treatment of bipolar depression.
Rona Jeannie, Roberts, Kavita K, Lohano, Rif S, El-Mallakh   +2 more
openaire   +2 more sources

Antipsychotics for delirium

2006
Delirium occurs in up to 30% of hospitalised patients and is associated with prolonged hospital stay and increased morbidity and mortality. Recently published reports have suggested that the standard drug for delirium, haloperidol, a typical antipsychotic that may cause adverse extrapyramidal symptoms among patients, may be replaced by atypical ...
E, Lonergan, A M, Britton, J, Luxenberg, T, Wyller   +3 more
openaire   +2 more sources

Antipsychotics and the microbiota

Current Opinion in Psychiatry, 2020
Purpose of review The gut microbiota has been speculated to underpin metabolic changes associated with chronic antipsychotic use. The change in the gut microbiota can also cause abnormal absorbtion from the gut into the blood stream (leaky gut syndrome) that can lead to inflammatory reactions, and thus, secondary damage to the ...
Anderson, Chen, Tae Yang, Park, Kevin J, Li, Lynn E, DeLisi   +3 more
openaire   +2 more sources